HomeCOEP • NASDAQ
Coeptis Therapeutics Holdings Inc
add
$15.74
13.40%
After Hours:(0.064%)+0.010
$15.75
Closed: Sep 22, 6:39:42 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
ORCL
6.31%
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 200.68K | — |
Operating expense | 4.68M | 65.37% |
Net income | -3.53M | -16.45% |
Net profit margin | -1.76K | — |
Earnings per share | — | — |
EBITDA | -4.23M | -63.93% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.99M | 92.10% |
Total assets | 12.19M | 190.38% |
Total liabilities | 5.11M | 13.37% |
Total equity | 7.08M | — |
Shares outstanding | 4.82M | — |
Price to book | 9.51 | — |
Return on assets | -88.15% | — |
Return on capital | -126.18% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -3.53M | -16.45% |
Cash from operations | -2.40M | -69.05% |
Cash from investing | — | — |
Cash from financing | 125.10K | -93.56% |
Net change in cash | -2.27M | -532.01% |
Free cash flow | -2.78M | -158.60% |
Previous close
$13.88
Day range
$13.86 - $15.79
Year range
$2.31 - $15.79
Market cap
75.87M USD
Avg Volume
49.13K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2017
Headquarters
Website
Employees
6